An increase in GPNMB levels in the brain has been found in a variety of neurodegenerative disorders, including AD [21], amyotrophic lateral sclerosis (ALS) [22], and Parkinson’s disease (PD) [23]. Here, GPNMB is linked to Parkinson disease.